Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity
• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]
merck
Merck launches new marine cosmetic ingredients during in-cosmeticsTM Asia 2022
Merck presents two new cosmetic active ingredients for the Asian Pacific market at this year’s in-cosmetics™ Asia that takes place in Bangkok from Nov 1-3: […]
Gerresheimer and Merck jointly developed a digital twin solution …
….to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. • Proof of Concept (PoC) successfully provides primary packaging with a […]
Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
Merck will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). • Company’s scientific leadership […]
Merck Highlights New Data for Evobrutinib…
…First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment This data suggests the long-term positive […]
Merck has launched the VirusExpress® 293 Adeno-Associated Virus (AAV) Production Platform
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform Merck has launched […]
Merck Announces Collaboration with Agilent Technologies
…to Fill Industry Gap in Process Analytical Technologies for Downstream Processing Merck today announced that it has entered a collaboration with Agilent Technologies to advance […]
Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System
The acquisition of the MAST® platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit. Merck to become first company to offer […]
Merck today announced several organizational changes and a new operating model to support the long-term growth strategy
….of the Life Science business sector. • New operating model to accelerate profitable growth strategy • Newly formed Life Science Services business unit to offer […]
Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA
Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted […]
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million
Merck today announced the expansion of its strategic, corporate venture capital arm M Ventures. Merck, a leading science and technology company, today announced the expansion […]
Merck Invests € 270 Million in a New Research Center and Vocational & Advanced Training in Darmstadt
Merck plans to invest € 270 million at its global headquarters in Darmstadt by building a new Translational Science Center for its Healthcare business sector […]
Merck Announces Investment of EUR 20 million to Expand its R&D and Manufacturing Site in Shizuoka, Japan
Merck, a leading science and technology company, today announced an investment of EUR 20 million to expand research and development and manufacturing capabilities at its […]
Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies
Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. € 25 million investment in Molsheim, France, will create […]
Merck Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power
Merck is an anchor buyer of a 12-year renewable energy contract for the Azure Sky wind and storage project in Texas, United States 68 megawatts […]